TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss

Overview of attention for article published in Cancer Cell International, April 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 12 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Targeting BAFFR chimeric antigen receptor, CAR-T cell and application

Application CN-117050195-A

China

TRANSFORMED ANTIGEN-SPECIFIC PROFESSIONAL ANTIGEN-PRESENTING CELL CONTAINING CHIMERIC…

Application WO-2022234976-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.